- Home
- TBBB vs PTGX Comparison
TBBB vs PTGX Comparison
Compare TBBB & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBBB
- PTGX
- Stock Information
- Founded
- TBBB 2004
- PTGX 2006
- Country
- TBBB Mexico
- PTGX United States
- Employees
- TBBB N/A
- PTGX N/A
- Industry
- TBBB
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- TBBB
- PTGX Health Care
- Exchange
- TBBB NYSE
- PTGX Nasdaq
- Market Cap
- TBBB 3.5B
- PTGX 2.9B
- IPO Year
- TBBB 2024
- PTGX 2016
- Fundamental
- Price
- TBBB $29.09
- PTGX $50.15
- Analyst Decision
- TBBB Buy
- PTGX Strong Buy
- Analyst Count
- TBBB 5
- PTGX 8
- Target Price
- TBBB $34.00
- PTGX $66.50
- AVG Volume (30 Days)
- TBBB 545.4K
- PTGX 820.5K
- Earning Date
- TBBB 05-07-2025
- PTGX 05-06-2025
- Dividend Yield
- TBBB N/A
- PTGX N/A
- EPS Growth
- TBBB N/A
- PTGX N/A
- EPS
- TBBB 0.16
- PTGX 0.86
- Revenue
- TBBB $3,027,881,094.00
- PTGX $207,801,000.00
- Revenue This Year
- TBBB $33.21
- PTGX N/A
- Revenue Next Year
- TBBB $27.75
- PTGX $50.30
- P/E Ratio
- TBBB $177.87
- PTGX $55.04
- Revenue Growth
- TBBB 31.48
- PTGX N/A
- 52 Week Low
- TBBB $21.39
- PTGX $28.36
- 52 Week High
- TBBB $35.22
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- TBBB N/A
- PTGX 66.59
- Support Level
- TBBB N/A
- PTGX $45.43
- Resistance Level
- TBBB N/A
- PTGX $46.80
- Average True Range (ATR)
- TBBB 0.00
- PTGX 1.59
- MACD
- TBBB 0.00
- PTGX 0.51
- Stochastic Oscillator
- TBBB 0.00
- PTGX 98.93
About TBBB BBB FOODS INC
BBB Foods Inc is a company offering a grocery hard discount model in Mexico. Also that operates through three subsidiaries namely Tiendas Tres B, Tiendas BBB and Desarrolladora Tres BSA de CV of which the main activity of Tiendas Tres B is the sale, purchase, distribution and marketing of all types of products, items and goods, as well as the establishment, and operation of individual stores and distribution centers for the sale of such products.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.